Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Neurology|April 28, 2004
Ropinirole for restless legs syndrome: a placebo-controlled crossover trialC H Adler, R A Hauser, K Sethi, et al.
Neurology|July 1, 1992
Epitope analysis of senile plaque components in the hippocampus of patients with Parkinson's diseaseH Arai, M L Schmidt, V M Lee, et al.
Neurology|March 4, 1998
Stereotactic pallidotomy for the treatment of Parkinson's disease. Efficacy and adverse effects at 6 months in 26 patientsK M Shannon, R D Penn, J S Kroin, et al.
Neurology|April 17, 2008
Pathologic findings in prospectively ascertained essential tremor subjectsH A Shill, C H Adler, M N Sabbagh, et al.
Brain Research|November 7, 2002
Loss of response to levodopa in Parkinson's disease and co-occurrence with dementia: role of D3 and not D2 receptorsJ N Joyce, H L Ryoo, T B Beach, et al.
Clinical Neuropharmacology|May 10, 2000
A home diary to assess functional status in patients with Parkinson's disease with motor fluctuations and dyskinesiaR A Hauser, J Friedlander, T A Zesiewicz, et al.
Parkinsonism & Related Disorders|June 1, 2002
Motor unit number estimates in idiopathic Parkinson's diseaseJ N Caviness, B E Smith, J Clarke Stevens, et al.
Neurology|January 1, 1997
Tolcapone improves motor function and reduces levodopa requirement in patients with Parkinson's disease experiencing motor fluctuations: a multicenter, double-blind, randomized, placebo-controlled trial. Tolcapone Fluctuator Study Group IM C Kurth, C H Adler, M S Hilaire, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2000
Motor unit changes in sporadic idiopathic Parkinson's diseaseJ N Caviness, B E Smith, J C Stevens, et al.
Archives of Neurology|August 26, 1998
Randomized, placebo-controlled study of tolcapone in patients with fluctuating Parkinson disease treated with levodopa-carbidopa. Tolcapone Fluctuator Study Group IIIC H Adler, C Singer, C O'Brien, et al.
Pageof 9